• Nano-Code: 2020-1-BG01-KA226-HE-095017
Partnership Area
What are you looking for?

Nanotechnology in detection, diagnosis and treatment of SARS-CoV-2

Interferons have proven effective in the treatment of SARS-CoV-2.

PT-PCR detection method can give false-negative results.

Serology tests are cheap.

Since SARS-CoV-2 is very new, repurposed drugs cannot be used for treatment of the associated infection.

Lipid-based drug carriers include liposomes, nanoemulsions and solid lipid particles.

Since SARS-CoV-2 is a lipid-enveloped virus, only lipid-based formulations may be used for encapsulation of viral components.

Nanotechnology-based solutions may be employed for diagnostics of SARS-CoV-2 infection and for treatment of COVID-19.

Virosomes have significant infective potential.

Categories of nanomaterials are all excpet:

Which of the below is not a RT-PCR disadvantage.

Leave a Reply